Ventavia Research Group, LLC

1. Moderna TX, Inc. $997,445 16 payments
2. Organon LLC $128,584 36 payments
3. H. Lundbeck A S $84,285 2 payments

1. A Phase 2/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus (RSV), in Adults 60 Years of Age $661,675 6 payments
2. A Phase 2/3, Two-Part, Open-Label, Dose Escalation, Age De-escalation and Randomized, Observer Blind, Placebo-Controlled Expansion Study to Evaluate the Safety, Tolerability, Reactogenicity, and Effectiveness of mRNA 1273 SARS-CoV-2 Vaccine in Health $326,269 5 payments
3. Og-8175A-023 $102,000 21 payments
4. Evaluate Efficacy & Safety of Eptinezumab Administered Intravenously in Subjects Experiencing Acute Attack of Migraine (RELIEF) $84,285 2 payments
5. Og-8175A-023 $26,584 15 payments
6. Phase 1/2, randomized, observer-blind, dose-ranging study to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1010 candidate seasonal influenza vaccine in healthy adults 18 years and older $9,250 3 payments
7. A Randomized, Observer-Blind, Active-Controlled Phase 3 Study to Investigate the Safety, Immunogenicity, and Relative Vaccine Efficacy of mRNA-1283.222 Administered as a Booster Dose Compared With mRNA-1273.222 in Participants Aged 12 Years and Older for the Prevention of COVID-19 $251 2 payments

1. Patient care $128,584 36 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.